Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

SPARK THERAPEUTICS, INC. — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report

SPARK THERAPEUTICS, INC.

via SPARK THERAPEUTICS, INC.

4th Quarter (Oct 1 - Dec 31) · 2020Posted Jan 21, 2021Filing document ↗LDA record ↗

Expenses$160Kself-filed spend

Client

Name: SPARK THERAPEUTICS, INC.
Location: Pennsylvania · United States of America

Registrant

Firm: SPARK THERAPEUTICS, INC.
Description: biotechnology
Location: Philadelphia, Pennsylvania, United States of America

Lobbying activities

1 issue

Medicare/Medicaid
Issues relating to the adoption of value-based payment arrangements.
LobbyistsJEREMY ALLEN
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.